Clinical Trial Update: Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001

View source ↗

Summary

A clinical trial update describing long-term follow-up plans for subjects dosed with NTLA-2001, with the study currently recruiting for ATTR-related conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin-related Familial Amyloid Cardiomyopathy
• Transthyretin-related Familial Amyloid Polyneuropathy
• Wild-type Transthyretin Cardiac Amyloidosis

Drugs mentioned

• NTLA-2001

Snippet

Sponsor: Intellia Therapeutics | Conditions: Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy | Status: RECRUITING